Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
DeepMatter
DeepMatter
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Cloud based smart chemistry platform
This single platform allows reaction data to be compiled from multiple data sources to provide a cleansed, harmonised, and categorised repository
Research & Development
DeepMatter provides software platform for University of Cambridge
DigitalGlassware is a cloud-based platform designed to allow scientists to bring together digitised synthesis protocols
Finance
DeepMatter appointments Non-Executive Director
The company will seek to leverage his knowledge to further develop its data platforms and ensure they meet the needs of the pharmaceutical industry
Research & Development
DeepMatter collaborates with universities on manufacturing
The company will provide its DigitalGlassware software, a cloud-based platform that allows chemists to share data in real-time and digitally enable scale-up of advanced nanoparticle products
Manufacturing
AstraZeneca chooses DeepMatter for optimisation of compound synthesis
DeepMatter has joined forces with AstraZeneca to improve productivity using digital equipment enabled with machine learning and AI
Subscribe now